Adult Vaccines Market, By Vaccines (Influenza, Tetanus, Diphtheria, Pertussis, Varicella, Human Papillomavirus, Zoster, Measles, Mumps, Rubella, Pneumococcal, Hepatitis, Others), By Vaccine Type, By Technology, By Geography

Description

Global adult vaccines market is estimated to be valued at USD 18.10 Bn in 2024 and is expected to reach USD 31.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.4% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 18.10 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	8.40%	2031 Value Projection:	US$ 31.80 Bn

Figure. Adult Vaccines Market Share (%), By Region 2024

Global adult vaccines market growth is driven by increasing investments by governments and private firms in adult vaccination programs. Adult vaccinations have gained popularity as these protect vulnerable groups from serious diseases and infections. Growing awareness about available vaccines and their benefits for adults has prompted more individuals to get vaccinated. Moreover, expansion of indications for existing adult vaccines and development of new formulations have strengthened prevention against various diseases affecting the adult population worldwide. However, high development costs and lack of adequate vaccination infrastructure in developing nations can hamper the market growth.

Market Dynamics:

Global adult vaccines market growth is driven by rising prevalence of diseases such as influenza, meningococcal meningitis, pneumococcal infection, and others among adults. According to the World Health Organization, seasonal influenza results in severe illness in around 3-5 million cases and 290,000-650,000 respiratory deaths globally every year. Increasing healthcare expenditures, favorable government support through vaccination programs and introduction of novel vaccines can drive the market growth. However, low awareness in developing countries, high R&D costs associated with development of new vaccines and storage requirements can hamper the market growth. Development of thermostable vaccines without refrigeration needs and combined adult vaccine formulations can offer opportunities for market players.

Key Features of the Study:

This report provides in-depth analysis of the global adult vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global adult vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline, Sanofi Pasteur, Merck, Novavax, Pfizer, and CSL Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global adult vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global adult vaccines market

Detailed Segmentation-

By Vaccines
- Influenza
- Tetanus, Diphtheria, Pertussis (Td/Tdap)
- Varicella
- Human Papillomavirus
- Zoster
- Measles, Mumps, Rubella (MMR)
- Pneumococcal
- Hepatitis
- Others
By Vaccine Type
- Monovalent
- Multivalent
By Technology
- Live Attenuated Vaccines
- Inactivated Viral/Bacterial Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Conjugate Vaccines
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi Pasteur
- AstraZeneca
- Johnson & Johnson
- Novavax, Inc.
- Moderna, Inc.
- Inovio Pharmaceuticals, Inc.
- Bavarian Nordic
- Dynavax Technologies Corporation
- BioNTech S
- Emergent BioSolutions Inc.
- Serum Institute of India Pvt. Ltd.
- Bharat Biotech
- Sinovac Biotech Ltd.

Product Code: CMI1091

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Vaccines
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Technology
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Adult Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Adult Vaccines Market, By Vaccines, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Influenza
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Tetanus, Diphtheria, Pertussis (Td/Tdap)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Varicella
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Human Papillomavirus
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Zoster
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Measles, Mumps, Rubella (MMR)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Pneumococcal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Hepatitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Adult Vaccines Market, By Vaccine Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Monovalent
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Multivalent
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Adult Vaccines Market, By Technology, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Live Attenuated Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Inactivated Viral/Bacterial Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Toxoid Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Recombinant Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Conjugate Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Adult Vaccines Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- GlaxoSmithKline plc
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi Pasteur
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AstraZeneca
- Johnson & Johnson
- Novavax, Inc.
- Moderna, Inc.
- Inovio Pharmaceuticals, Inc.
- Bavarian Nordic
- Dynavax Technologies Corporation
- BioNTech S
- Emergent BioSolutions Inc.
- Serum Institute of India Pvt. Ltd.
- Bharat Biotech
- Sinovac Biotech Ltd.

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us and Sales Contact